Suchergebnisse - "Yang, J-W"

PubPharm (6)

1

Pembrolizumab versus chemotherapy for patients with esophageal squamous cell carcinoma enrolled in the randomized KEYNOTE-181 trial in Asia

enthalten in: ESMO open | 2022

von Cao, Y. | Qin, S. | Luo, S. | +25

2

The impact of weight management and related diuretic medication intervention based on body weight changes on cardiac function and re-hospitalization rate in patients with chronic congestive heart failure

enthalten in: Zhonghua xin xue guan bing za zhi | 2017

von Wang, F. | Shi, J. | Shi, J. | +6

3

Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)

enthalten in: Annals of medicine | 2010

von Li, J. | Lu, Z. | Kou, W. | +105

4

Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction : data from the Chinese Coronary Secondary Prevention Study (CCSPS)

enthalten in: Clinical and experimental hypertension (New York, N.Y. : 1993) | 2010

von Li, J. | Lu, Z. | Kou, W. | +105

5

Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)

enthalten in: Journal of clinical pharmacology | 2009

von Li, J. | Lu, Z. | Kou, W. | +105

6

Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction

enthalten in: The American journal of cardiology | 2008

von Lu, Z. | Kou, W. | Du, B. | +107

1
[1]